# Next steps

**Funder:** Cancerfonden
**Deadline:** 15 December 2026
**Consortium:** Required — utilisation/commercialisation partner for implementation or industry uptake
**TRL:** 6-9
**Frequency:** Annual
**Eligible countries:** SE
**Official call:** https://www.cancerfonden.se/forskning/for-forskare/sok-anslag-for-forskare/anvisning-next-steps
**Last updated:** 13 Sept 2026

## Eligibility & scope

Supports moving promising research results forward towards patient benefit, commercialisation or implementation in healthcare.

## Summary

Cancerfonden's Next Steps grant funds late-stage cancer research (TRL 6-9) to move promising results toward patient benefit, commercialization, or implementation in Swedish healthcare. It requires a consortium including a utilisation or commercialisation partner to support industry uptake or clinical implementation, and is open to research groups based in Sweden. Cancerfonden runs this call annually.

## Who should apply

- Research teams with results at TRL 6-9, close to clinical or commercial application
- Applicants based at Swedish research institutions
- Projects targeting patient benefit, commercialization, or healthcare implementation
- Teams able to secure a utilisation or commercialisation partner (industry or implementation partner)

## Key dates

- Deadline: 15 December 2026
- Recurring annual call

## Tips for applicants

- Secure and document your utilisation/commercialisation partner early, this consortium requirement is gating, not optional.
- Frame the proposal around TRL progression: reviewers expect clarity on where the project sits between 6 and 9 and what milestone it reaches next.
- Emphasise the pathway to patient benefit or industry uptake explicitly, since this distinguishes the call from earlier-stage discovery grants.

## Frequently asked questions

### What TRL level does the Cancerfonden Next Steps grant require?

Projects should be at TRL 6-9, meaning results are already demonstrated in relevant environments and moving toward real-world application.

### Do I need a partner to apply for Next Steps?

Yes, a consortium including a utilisation or commercialisation partner for implementation or industry uptake is required.

### Who is eligible for the Cancerfonden Next Steps grant?

Applicants must be based in Sweden, working on cancer research results ready to move toward patient benefit, commercialization, or healthcare implementation.

### Is the Cancerfonden Next Steps grant a recurring call?

Yes, it runs annually, with the current deadline set for 15 December 2026.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/cancerfonden-next-steps-2026-12) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).